Plenco 01523

Product Description

Plenco 01523 was a phenolic molding compound manufactured by Plenco Plastics, a Wisconsin-based producer of thermosetting plastic materials. Phenolic compounds of this type belonged to a broad category of industrial plastics engineered to withstand high temperatures, resist electrical conduction, and maintain structural integrity under mechanical stress. These properties made phenolic molding compounds attractive to manufacturers producing components for electrical equipment, automotive parts, industrial machinery, and similar applications where conventional thermoplastics would fail under operating conditions.

Plenco Plastics developed and marketed a range of phenolic compounds under numbered product designations, with Plenco 01523 representing one specific formulation within that product line. As with many phenolic compounds produced during the mid-twentieth century, the formulation of Plenco 01523 reportedly incorporated asbestos fiber as a functional additive. Asbestos was valued in these compounds for its ability to reinforce the resin matrix, improve dimensional stability during the molding process, and enhance the material’s resistance to heat and flame. Phenolic compounds reinforced with asbestos were considered high-performance industrial materials and were widely used in production environments across multiple industries.

The commercial production and distribution of asbestos-reinforced phenolic compounds occurred during a period when the hazards of asbestos fiber exposure were known within scientific and industrial literature but were not broadly communicated to workers handling such materials on production floors. Workers who processed, molded, and machined these compounds often did so without adequate protective equipment or engineering controls.

Asbestos Content

Plenco 01523 belonged to the category of asbestos-reinforced phenolic molding compounds. In this class of materials, asbestos fibers—typically chrysotile, although amphibole varieties were also used in industrial formulations during certain periods—were blended into a phenolic resin binder prior to the molding process. The resulting compound could be supplied in granular, pelletized, or powder form for use in compression or transfer molding operations.

The asbestos fibers distributed throughout the resin matrix served multiple technical functions: they acted as a reinforcing filler to prevent cracking and warping, improved the flow characteristics of the compound during molding, and contributed to the fire-resistance and thermal stability of the finished part. In its cured and undisturbed state, asbestos fiber within a molded phenolic part may be partially encapsulated within the resin. However, during the stages of manufacture, processing, finishing, and repair, the material presented significant fiber release potential.

Litigation records document that plaintiffs who worked with Plenco 01523 and comparable asbestos-reinforced phenolic compounds alleged that these products contained asbestos in quantities sufficient to generate hazardous airborne fiber concentrations during normal industrial use.

How Workers Were Exposed

Exposure to asbestos fibers from Plenco 01523 occurred primarily during the handling and processing of the compound in its pre-cured and post-cured forms. Industrial workers involved in the production of molded parts, component fabrication, and equipment maintenance were among those identified in litigation as having potential exposure.

Handling of Raw Compound: Prior to molding, the compound existed as a granular or powdered material. Workers who weighed, transferred, loaded, or otherwise handled the raw compound could disturb the material and release airborne dust containing asbestos fibers. In poorly ventilated or uncontrolled environments, these fiber concentrations could persist and be inhaled by workers in the immediate area.

Molding Operations: During compression and transfer molding, the compound was subjected to heat and pressure to form finished parts. Workers operating molding presses, removing parts from molds, and cleaning mold surfaces encountered residual compound dust and flash—thin excess material at part edges—that could release asbestos fibers when handled or removed.

Machining, Grinding, and Finishing: After molding, phenolic parts frequently required secondary operations including drilling, grinding, sanding, trimming, and polishing to achieve final dimensions and surface quality. These dry machining processes generated substantial quantities of fine dust. Litigation records document that plaintiffs alleged these finishing operations produced airborne asbestos fiber concentrations that workers inhaled over extended periods, often without respiratory protection.

Maintenance and Repair Activities: Workers involved in maintaining machinery that incorporated phenolic components, or in repairing molded parts, could also disturb cured material and release trapped asbestos fibers. Breakage, cutting, and abrasive wear of in-service parts were identified as additional pathways for fiber release in occupational settings.

Adjacent and Bystander Exposure: In facilities where Plenco 01523 or similar compounds were processed, workers in adjacent areas could be exposed to airborne fibers that migrated through shared workspaces, particularly in open-plan production floors without effective dust containment.

Plaintiffs alleged that Plenco Plastics knew or should have known about the health hazards associated with asbestos fiber inhalation, and that adequate warnings were not provided to workers who handled Plenco 01523 during the years the product was in use. Diseases documented in connection with asbestos exposure include mesothelioma, asbestosis, lung cancer, and other asbestos-related conditions, with latency periods that can extend decades beyond the original exposure.

Documented Trust Fund / Legal Options

Plenco 01523 is classified as a Tier 2 litigated product. There is no established asbestos bankruptcy trust fund specifically associated with Plenco Plastics at this time. Legal claims related to this product have proceeded through civil litigation rather than through a structured trust fund claims process.

Civil Litigation: Litigation records document that plaintiffs diagnosed with mesothelioma, asbestosis, lung cancer, and related asbestos diseases have brought claims in connection with exposure to asbestos-containing phenolic compounds, including products manufactured by Plenco Plastics. Plaintiffs alleged product liability, failure to warn, and negligence on the part of manufacturers who incorporated asbestos into these compounds without providing adequate hazard communication to end users.

Potential Third-Party Claims: Because Plenco 01523 was used as a raw material in the manufacture of finished components, plaintiffs in some cases pursued claims against multiple parties in the production and distribution chain, including equipment manufacturers who incorporated asbestos-reinforced phenolic parts into their products.

Workers’ Compensation: In some jurisdictions and circumstances, workers’ compensation may provide a pathway for compensation for occupational asbestos disease, though such remedies are generally considered separate from and more limited than civil tort claims.

Steps for Affected Individuals:

• Compile a detailed occupational history documenting specific products handled, job duties, facility locations, and approximate dates of exposure
• Obtain a confirmed medical diagnosis from a physician experienced in asbestos-related disease
• Consult an attorney specializing in asbestos litigation to evaluate the viability of civil claims

Individuals who believe they were exposed to Plenco 01523 or comparable asbestos-reinforced phenolic compounds during their working years should seek legal consultation promptly, as statutes of limitations vary by jurisdiction and are typically measured from the date of diagnosis rather than the date of exposure.